The figure 25.3 % surpasses: Tirzepatide SURMOUNT-1: 22.5 % Semaglutide STEP-1: 14.9 % Retatrutide Phase 2: 24.2 % (comparable, but Phase 3 results for Retatrutide are still lacking) It raises the question whether CagriSema will be the first molecule with an effect truly comparable to bariatric surgery (typically 2530 % reduction)
Gaba-modulating bacteria of the human gut microbiota
The correct dosage of B12 varies considerably depending on whether you are maintaining adequate levels, preventing deficiency, or treating diagnosed B12 deficiency
[6] These are minutes, not hours which is why clinical dosing of both has been once-daily subcutaneous injection, and why any marketing that implies a single injection produces long-lasting circulating peptide activity is misleading
In animal models of nephrotic syndrome, a decrease in gut microbial diversity has been observed, accompanied by a compositional shift from Firmicutes to Bacteroidetes and alterations in specific bacterial taxa that increase the production of precursors for harmful metabolites and uremic toxins [147]
